[go: up one dir, main page]

PE20121728A1 - Polvos nutricionales que comprenden hmb secado por aspersion - Google Patents

Polvos nutricionales que comprenden hmb secado por aspersion

Info

Publication number
PE20121728A1
PE20121728A1 PE2012001076A PE2012001076A PE20121728A1 PE 20121728 A1 PE20121728 A1 PE 20121728A1 PE 2012001076 A PE2012001076 A PE 2012001076A PE 2012001076 A PE2012001076 A PE 2012001076A PE 20121728 A1 PE20121728 A1 PE 20121728A1
Authority
PE
Peru
Prior art keywords
spray dried
including spray
powders including
nutritional powders
composition
Prior art date
Application number
PE2012001076A
Other languages
English (en)
Inventor
Charles R Helmke
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PE20121728A1 publication Critical patent/PE20121728A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00Preservation of foods or foodstuffs, in general
    • A23B2/90Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
    • A23B2/93Spray drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN POLVO NUTRICIONAL QUE COMPRENDE A) DE 0,1% A 8% DE BETA-HIDROXI-BETA-METILBUTIRATO (HMB) DE CALCIO MONOHIDRATO EN PESO DE LA COMPOSICION; B) DE 5% A 75% DE PROTEINAS EN PESO DE LA COMPOSICION; C) DE 20% A 90% DE CARBOHIDRATOS EN PESO DE LA COMPOSICION; Y D) DE 5% A 75% DE GRASAS EN PESO DE LA COMPOSICION. EN DONDE DICHO POLVO NUTRICIONAL ES SECADO POR ASPERSION. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION DE DICHO POLVO NUTRICIONAL
PE2012001076A 2010-01-29 2011-01-28 Polvos nutricionales que comprenden hmb secado por aspersion PE20121728A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29963210P 2010-01-29 2010-01-29

Publications (1)

Publication Number Publication Date
PE20121728A1 true PE20121728A1 (es) 2013-01-13

Family

ID=43927918

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012001076A PE20121728A1 (es) 2010-01-29 2011-01-28 Polvos nutricionales que comprenden hmb secado por aspersion

Country Status (19)

Country Link
US (1) US20110256299A1 (es)
EP (1) EP2442673B1 (es)
JP (1) JP5892947B2 (es)
CN (2) CN102711523A (es)
AR (1) AR089547A1 (es)
AU (1) AU2011210683A1 (es)
BR (1) BR112012018642A2 (es)
CA (1) CA2785524C (es)
CO (1) CO6592060A2 (es)
EC (1) ECSP12012053A (es)
ES (1) ES2426481T3 (es)
IL (1) IL220588A0 (es)
MX (1) MX2012008778A (es)
PE (1) PE20121728A1 (es)
PH (1) PH12012501350A1 (es)
RU (1) RU2012125879A (es)
SG (1) SG182813A1 (es)
TW (1) TWI508670B (es)
WO (1) WO2011094549A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011210691A1 (en) 2010-01-29 2012-07-12 Abbott Laboratories Nutritional emulsions comprising calcium HMB
JP6076741B2 (ja) 2010-01-29 2017-02-08 アボット・ラボラトリーズAbbott Laboratories 無菌包装されているhmbを含む栄養液
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣hmb及可溶性蛋白質之實質上透明營養液
WO2013110958A1 (en) * 2012-01-23 2013-08-01 Dellis Medical Research Unlimited Co. Triglyceride tolerance test meal
US20140037813A1 (en) * 2012-08-02 2014-02-06 Mead Johnson Nutrition Company Nutritional creamer composition
MX2015013165A (es) * 2013-03-15 2015-12-11 Abbott Lab Composiciones nutricionales para infantes prematuros que contienen acido beta-hidroxi-beta-metilbutirico para promover el crecimiento y la acrecion de masa corporal magra en infantes prematuros.
BR112015023316A2 (pt) * 2013-03-15 2017-07-18 Abbott Lab fórmula para bebês de baixa caloria contendo ácido beta-hidroxi-beta-metilbutírico para promover a síntese de proteína e a acreção de massa corporal magra em bebês nascidos a termo
CA2920789C (en) 2015-06-04 2021-05-18 Advance International, Inc. Improved methods and systems for recovering protein powder and natural omega-3 oil from animal tissue
CN107660793A (zh) * 2016-07-29 2018-02-06 费森尤斯卡比德国有限公司 营养粉及其生产方法
US11297873B2 (en) 2016-09-13 2022-04-12 Abbott Laboratories Ketogenic nutritional compositions
JP6889879B2 (ja) * 2017-03-31 2021-06-18 株式会社東洋新薬 チュアブルタブレット
JP7100882B2 (ja) * 2017-11-08 2022-07-14 株式会社東洋新薬 経口組成物
SG11202009709PA (en) 2018-04-06 2020-10-29 Abbott Lab Powdered nutritional compositions with hmb and protein system
WO2020023557A1 (en) 2018-07-23 2020-01-30 Advance International Inc. Protein-based therapeutic nutritional products

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291525B1 (en) * 1999-09-08 2001-09-18 Iowa State University Research Foundation, Inc. Method for improving a human's perception of his emotional state
AU784752B2 (en) * 1999-10-18 2006-06-08 Northern Innovations Holding Corp. Food supplement for increasing lean mass and strength
KR20020090214A (ko) * 2000-02-01 2002-11-30 머슬테크 리서치 앤드 디벨롭먼트, 인크. 근육을 키우거나 강도를 늘리기 위한 α리포산계의보조식품
US6521591B1 (en) * 2000-02-10 2003-02-18 N.V. Nutricia Pharmaceutical composition for muscular anabolism
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US7332178B2 (en) * 2003-04-25 2008-02-19 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
NO323912B1 (no) * 2005-12-01 2007-07-16 Tine Sa Sammensetning, fremgangsmåte til fremstilling derav, og anvendelse derav.
AU2006331950A1 (en) * 2005-12-19 2007-07-05 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance of type 1 and type 2 cytokine production
JP2008208118A (ja) * 2007-01-29 2008-09-11 Wakunaga Pharmaceut Co Ltd ツルニンジン属植物抽出物含有粉末組成物
CN101574146B (zh) * 2008-05-07 2012-06-13 北京康比特体育科技股份有限公司 一种含有hmb的运动营养补剂

Also Published As

Publication number Publication date
RU2012125879A (ru) 2014-03-10
ES2426481T3 (es) 2013-10-23
EP2442673B1 (en) 2013-07-10
EP2442673A1 (en) 2012-04-25
TW201200037A (en) 2012-01-01
JP5892947B2 (ja) 2016-03-23
CN102711523A (zh) 2012-10-03
JP2013517806A (ja) 2013-05-20
TWI508670B (zh) 2015-11-21
CA2785524A1 (en) 2011-08-04
BR112012018642A2 (pt) 2015-09-01
AU2011210683A1 (en) 2012-07-05
HK1165227A1 (en) 2012-10-05
PH12012501350A1 (en) 2016-07-08
US20110256299A1 (en) 2011-10-20
CN106937742A (zh) 2017-07-11
MX2012008778A (es) 2012-09-07
CO6592060A2 (es) 2013-01-02
SG182813A1 (en) 2012-09-27
CA2785524C (en) 2015-10-13
IL220588A0 (en) 2012-08-30
WO2011094549A1 (en) 2011-08-04
AR089547A1 (es) 2014-09-03
ECSP12012053A (es) 2012-08-31

Similar Documents

Publication Publication Date Title
PE20121728A1 (es) Polvos nutricionales que comprenden hmb secado por aspersion
MX2020005781A (es) 3-fucosil-lactosa secada por aspersion.
EA201990851A1 (ru) Новые аналоги карбануклеозида, замещенные моноциклической и бициклической кольцевой системой, для применения в качестве ингибиторов prmt5
MX2022012374A (es) Composiciones multi-suplementos.
EP3699176A3 (en) Antiviral compounds
MY161773A (en) Amylin analogues and pharmaceutical compositions thereof
MX342838B (es) Compuestos y composiciones de guanidina para la inhibicion de nampt.
MY156928A (en) Stabilized bio-available soluble silicate solution
MX2018013335A (es) Derivados de piridiniltriazol sustituidos con amida y usos de estos.
BR112012017564A2 (pt) Formulação antimicrobiana
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
PH12013500319A1 (en) Conversion of 5-(chloromethyl)-2-furaldehyde into 5-methyl-2-furoic acid and derivatives thereof
EP4327880A3 (en) Solid state form of ribociclib succinate
MX2018003926A (es) Composicion para mejorar el rendimiento.
PH12019501362A1 (en) Polymorphs
MX2017008431A (es) Compuestos ciclicos sustituidos con un sistema de anillos condensado.
GT201300064A (es) Monohidrato de derivados de aza-adamantano
MX2012013610A (es) Complejo obtenido a partir de mezclas de acido hialuronico o una sal del mismo y sulfato de condroitina.
PH12020550947A1 (en) Polymorphs
CL2017000153A1 (es) Composiciones de azúcares para la formación de comprimidos mediante compresión directa
MX376472B (es) Material semisintetico en polvo, obtenido al modificar la composicion de un biomaterial marino natural, metodo para su produccion y sus aplicaciones.
ZA200905690B (en) Compositions comprising peg-interferon alpha conjugates and raffinose as cryoprotectant
BR112016013667A2 (pt) Composições condicionadoras
MX350569B (es) Composicion farmaceutica estable para el tratamiento de osteoporosis.
MX2018005730A (es) Color derivado de caramelo con brillantez incrementada.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal